Literature DB >> 7923057

Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.

G R Merlo1, T Venesio, A Bernardi, C S Cropp, F Diella, A P Cappa, R Callahan, D S Liscia.   

Abstract

The short area of chromosome 17 is a frequent target for deletions in human tumors, including breast cancer. We have investigated by restriction fragment polymorphism analysis the pattern of loss of heterozygosity (LOH) at four loci on 17p13.1-17pter in a panel of 110 primary human breast carcinomas. A copy of the p53 gene was lost in 23% of the informative cases. Point mutations in the p53 gene were statistically associated with LOH at the same locus (p = 0.003) but not at other loci on 17p13.3-17pter. A second region bordered by the loci D17S5/D17S28 (17p13.3) and D17S34 (17pter) is also affected by LOH, independent of point mutations in the p53 gene. We propose the presence of a second tumor suppressor gene within this region. In support of this hypothesis is the significant association (p = 0.005) between LOH at the D17S5/D17S28, but not at the TP53 or D17S34 loci, and tumors having a high S-phase index.

Entities:  

Mesh:

Year:  1994        PMID: 7923057     DOI: 10.1016/0165-4608(94)90458-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.

Authors:  C S Herrington; M Worsham; S A Southern; P Mackowiak; S R Wolman
Journal:  Mol Pathol       Date:  2001-06

2.  Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.

Authors:  Chun-Ming Chen; Richard R Behringer
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

3.  Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.

Authors:  D S Liscia; R Morizio; T Venesio; C Palenzona; M Donadio; R Callahan
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.

Authors:  G R White; M Stack; M Santibáñez-Koref; D S Liscia; T Venesio; J C Wang; C Helms; H Donis-Keller; D C Betticher; H J Altermatt; P R Hoban; J Heighway
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.